Veralto (VLTO) Q2 2025 10-Q Quarterly Report
Filed: Apr 30, 2025Period ending Apr 4, 2025
Health Care
Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR Veralto (VLTO) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Apr 30, 2025 for the fiscal period ending Apr 4, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Veralto Q2 2025 10-Q Analysis
Risk Factors
- • New trade restriction risk triggered by U.S. government imposing significant tariffs since January 2025 on imports from China and other countries
- • Most materially updated risk: impact of retaliatory tariffs and political tensions on global economic conditions and financial market stability
Veralto Q2 2025 Quarterly FinancialsXBRL
Revenue
$1.3B
▲ +6.9% YoY
Net Income
$225M
▲ +22.3% YoY
Net Margin
16.9%
▲ +212bp YoY
Source: XBRL data from Veralto Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Veralto Quarterly Reports
Get deeper insights on Veralto
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.